WallSt.net Airing Exclusive Audio Interviews With CBAI, GEECF, AEMD and ASTM
April 18 2005 - 8:00AM
PR Newswire (US)
WallSt.net Airing Exclusive Audio Interviews With CBAI, GEECF, AEMD
and ASTM NEW YORK, April 18 /PRNewswire/ -- Matt Schissler,
Chairman and CEO of Cord Blood America, Inc. (OTC:CBAI) (BULLETIN
BOARD: CBAI) recently granted Wall Street Network an exclusive
audio interview profiling the company. Interview highlights include
discussions on the following topics: -- 167 percent revenue growth
in 2004 over 2003 -- umbilical cord blood stem cell preservation
and storage industry growth -- keeping pace with industry growth --
management bios -- competitive edge -- mergers and acquisitions
strategy -- upcoming milestones To hear the interview in its
entirety and to read an in-depth report on the company, visit
http://wallst.net/superstock/CBAI/cbai.html Christopher McCormack,
President and CEO of Global Environmental Energy Corp. (OTC:GEECF)
(BULLETIN BOARD: GEECF) recently granted Wall Street Network an
exclusive audio interview profiling the company. Interview
highlights include discussions on the following topics: -- recent
agreement with Quickflow S.A. -- intellectual property -- recent
sales -- capitalization -- management bios -- upcoming milestones
Jim Joyce, Chairman, President and CEO of Aethlon Medical, Inc.
(OTC:AEMD) (BULLETIN BOARD: AEMD) recently granted Wall Street
Network an exclusive audio interview profiling the company.
Interview highlights include discussions on the following topics:
-- Feedback from the National Aids Conference -- Hemopurifier(TM)
technology, and its effectiveness with drug resistant HIV and
Hepatitis C patients -- HIV and Hepatitis C trials in India --
Financial position -- Management bios -- Upcoming clinical
milestones Douglas Armstrong, PhD, Chairman and CEO of Aastrom
Biosciences, Inc. (NASDAQ:ASTM) recently granted Wall Street
Network an exclusive audio interview profiling the company.
Interview highlights include discussions on the following topics:
-- recent expansion of clinical trials -- financial position --
competitive edge in the cell-therapy arena -- an update on European
clinical trails -- timelines for IND submission -- upcoming
clinical milestones To hear the interviews in their entirety, visit
http://www.wallst.net/. The interviews can be accessed by locating
the respective company's ticker symbol under the exchange on which
it trades on the left hand column of the homepage, or by entering
the respective company's ticker symbol in the Audio Search window.
About Wall Street Network Wall Street Network is owned and licensed
by Wall Street Direct, Inc. All material herein was prepared by
Digital Wall Street, Inc., a multimedia provider of original,
insightful commentary and news from North America's leading
publicly traded companies giving a direct link to the management of
today's fastest-growing companies through encompassing executive
interviews and sector seminars. The company provides a free service
to consumers, and a paid, premium monthly subscription to its
members. Digital Wall Street Inc. has received five hundred
thousand restricted shares from the company for press and
advertising services, and is expecting to receive an additional
five hundred thousand restricted shares from the company for press
and advertising services for CBAI. Digital Wall Street, Inc. has
received three thousand dollars from a third party for press and
advertising services for GEECF. Digital Wall Street, Inc. has
received three thousand seven hundred fifty dollars from AEMD for
the press and advertising services. For a complete list of our
business relationships, visit http://www.wallst.net/disclaimer.asp.
Contact Nick Iyer Digital Wall Street, Inc. 800 4 WALL ST
DATASOURCE: Wall Street Network CONTACT: Nick Iyer of Digital Wall
Street, Inc., +1-800-4-WALL-ST Web site:
http://wallst.net/superstock/CBAI/cbai.html http://www.wallst.net/
Copyright